Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 1:31 AM
NCT ID:
NCT01030094
Eligibility Criteria:
Inclusion Criteria:
* Participants who agree to participate in this study
* Female epileptic participants
* Participants who are receiving topiramate, carbamazepine or valproic acid monotherapy for more than one year
* Participants who are using proper contraceptive method (s) or have a negative pregnancy test result
Exclusion Criteria:
* Participants with a motor function disorder
* Participants with a disease which affects their skeleton including primary hyperparathyroidism, Paget's disease, multiple myeloma, liver and kidney disorder, thyroid disease, malabsorption disorder, diabetes, and malignancies
* Participants who have taken within last one year, or are currently taking a drug which affects the bone and mineral metabolism such as vitamin D, calcium, anabolic steroids, bisphosphonates, calcitonin, glucocorticoids, and diuretics
* Voluntary or surgical postmenopausal participants
* Participants with amenorrhea for more than 6 months
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT01030094
Study Brief:
Protocol Section:
NCT01030094